Kei Kimura1*, Yuko Kuroda1*, Yuta Masuda1*, Arito Yamane2*, Hikaru Hattori3*, Kenichi Tahara, MD4*, Ayaka Kaneko1*, Itsumi Suda1*, Noriyuki Takahashi1*, Nanami Gotoh1*, Kie Nagai1*, Tomomi Nagashima1*, Takayuki Saitoh, MD, PhD1*, Hirono Iriuchishima, MD, PhD4*, Makiko Takizawa, PhD, MD4*, Hiromi Koiso4*, Takuma Ishizaki4*, Takeki Mitsui4*, Hiroaki Shimizu, M.D., PhD.5*, Akihiko Yokohama, MD, PhD6, Norifumi Tsukamoto, MD, PhD5, Tetsuhiro Kasamatsu1*, Yusuke Minato, PhD7*, Yoshihisa Nojima4*, Hirokazu Murakami, MD1 and Hiroshi Handa, MD, PhD4
1Department of Laboratory Science, Gunma University Graduate School of Health Sciences, Gunma, Japan
2Department of Molecular Pharmacology and Oncology, Gunma University Graduate School of Medicine, Gunma, Japan
3Nagoya University Hospital, Aichi, Japan
4Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine, Gunma, Japan
5Oncology Center, Gunma University Hospital, Gunma, Japan
6Blood Transfusion Service, Gunma University Hospital, Gunma, Japan
7Department of Virology and Preventive Medicine, Gunma University, Gunma, Japan